| ETS | PRESS-RELEASE | bearish | 7/10 | Elite Express reported Q2 2026 revenue of $726,829 (+15.3% YoY) and gross profit improvement to $81,037 from $18,002, bu | Jul 14, 2026 |
| CELC | PRESS-RELEASE | bullish | 8/10 | Celcuity announced FDA approval of REVTORPYK (gedatolisib) for HR+/HER2- locally advanced or metastatic breast cancer wi | Jul 14, 2026 |
| COSM | PRESS-RELEASE | neutral | 3/10 | Cosmos Health announced the repurchase of an additional 133,000 shares at ~$0.298/share, bringing total repurchases unde | Jul 14, 2026 |
| DUK | PRESS-RELEASE | neutral | 2/10 | Duke Energy declared a quarterly cash dividend of $1.085 per share, a $0.02 increase from the prior quarter. This is a r | Jul 14, 2026 |
| CTS | PRESS-RELEASE | neutral | 1/10 | CTS Corporation announced it will report its Q2 2026 results. | Jul 14, 2026 |
| INIO | PRESS-RELEASE | neutral | 1/10 | INNIO Holding GmbH announced it will report its Q2 2026 results on July 28, 2026. | Jul 14, 2026 |
| L | PRESS-RELEASE | neutral | 1/10 | Loews Corporation announced it will report its Q2 2026 results on August 3, 2026. | Jul 14, 2026 |
| CNA | PRESS-RELEASE | neutral | 1/10 | CNA Financial announced it will report its Q2 2026 results on August 3. | Jul 14, 2026 |
| DTE | PRESS-RELEASE | neutral | 1/10 | DTE Energy announced it will report its Q2 2026 results on July 28, 2026. | Jul 14, 2026 |
| BIIB | PRESS-RELEASE | bullish | 7/10 | Biogen announced Phase 2 CELIA data for diranersen, an anti-tau ASO, showing clinical slowing on CDR-SB (26% at 60 mg) a | Jul 14, 2026 |
| QUCY | PRESS-RELEASE | neutral | 2/10 | Quantum Cyber announced a provisional patent filing for a modular drone launch system, but provided no financial details | Jul 14, 2026 |
| LIFE | PRESS-RELEASE | neutral | 2/10 | Ethos Technologies announced a national campaign partnership with Amanda Kloots to promote life insurance awareness. The | Jul 14, 2026 |
| HLLY | 8-K, PRESS-RELEASE | bullish | 4/10 | Holley Inc. announced an additional $15 million voluntary prepayment of its first lien term loan, bringing cumulative de | Jul 14, 2026 |
| TLS | PRESS-RELEASE | neutral | 3/10 | Telos Corporation announced the continuation of its partnership with the Hawaii Department of Transportation (HDOT) to p | Jul 14, 2026 |
| SILO | PRESS-RELEASE | bullish | 4/10 | Silo Pharma announced via press release that its wholly owned AI-agent subsidiary, QwikAgents, has been accepted into th | Jul 14, 2026 |
| LPLA | PRESS-RELEASE | bullish | 4/10 | LPL Financial announced that the advisors of HighWater Wealth, representing approximately $2.4 billion in advisory asset | Jul 14, 2026 |
| ERNA | PRESS-RELEASE | neutral | 3/10 | Ernexa Therapeutics released a CEO Corner video discussing ERNA-101, its lead cell therapy candidate for ovarian cancer, | Jul 14, 2026 |
| SYY | PRESS-RELEASE | neutral | 1/10 | Sysco Corporation announced it will report its fiscal Q4 2026 and full-year results on August 4. | Jul 14, 2026 |
| GVH | PRESS-RELEASE | bearish | 5/10 | Globavend reported H1 FY2026 revenue of $14.8M (+8% YoY) but swung to an operating loss of $370K from $789K operating in | Jul 14, 2026 |
| ALKT | PRESS-RELEASE | neutral | 1/10 | Alkami Technology, Inc. announced it will report its Q2 2026 results. | Jul 14, 2026 |
| CDRO | PRESS-RELEASE | neutral | 1/10 | Codere Online Luxembourg, S.A. announced it will report its Q2 2026 results on July 30. | Jul 14, 2026 |
| CRMT | PRESS-RELEASE | bearish | 9/10 | America's Car-Mart reported a disastrous Q4 FY2026 with EPS of -$3.56 (vs consensus -$0.59, a 503% miss) and total reven | Jul 14, 2026 |
| DSX | PRESS-RELEASE | neutral | 1/10 | Diana Shipping Inc. c/o Diana Shipping Services S.A. announced it will report its Q2 2026 results on July 30, 2026. | Jul 14, 2026 |
| OCTV | PRESS-RELEASE | neutral | 1/10 | Octave Intelligence plc announced it will report its Q2 2026 results on August 12. | Jul 14, 2026 |
| GTX | PRESS-RELEASE | neutral | 1/10 | Garrett Motion Inc. announced it will host a conference call on July 29, 2026 to discuss its Q2 2026 results. | Jul 14, 2026 |
| KURA | PRESS-RELEASE | neutral | 5/10 | Kura Oncology announced an oral presentation of updated Phase 1a data from its FIT-001 trial of darlifarnib plus cabozan | Jul 14, 2026 |
| DD | PRESS-RELEASE | neutral | 1/10 | DuPont announced it will host a conference call on August 4, 2026 to discuss its Q2 2026 results. | Jul 14, 2026 |
| BWMN | PRESS-RELEASE | neutral | 1/10 | Bowman Consulting Group, Ltd. announced it will report its Q2 2026 results on August 10, 2026. | Jul 14, 2026 |
| AVIR | PRESS-RELEASE | bullish | 5/10 | Atea Pharmaceuticals initiated a first-in-human Phase 1 trial of AT-587 for hepatitis E virus (HEV), a disease with no a | Jul 14, 2026 |
| KBR | PRESS-RELEASE | bullish | 5/10 | KBR announced it was selected for the ASTRA IDIQ contract by NASIC with an $866 million ceiling value across all awardee | Jul 14, 2026 |
